24/7 Wall St. » Search Results » GSX

24/7 Wall St. Closing Bell (AAPL, ARMH, QCOM, ZNGA, HALO, CWTR, FTK, HOTT, KFY, AONE, ACHN, FSYS, JKS, NAV, NGSX, SFD, SMRT, STP, VRS, STLY, MWA, SSH, ZLTQ)

Paul Ausick — Thu, 08 Mar 2012 21:05:38 +0000

The three major US equities indexes opened higher this morning on the news from Europe that the Greek debt swap deal would be a success. That prediction turned out to be solid, as about 80% of Greek bondholders agreed to the swap, taking pressure of the Greeks at least for the time being. The US new jobless claims number came in a bit higher than expected this morning, but traders hardly noticed. Tomorrow’s non-farm payrolls report is the one everyone’s waiting for, with a consensus estimate of 210,000 new jobs. The dollar opened weaker today, and has continued to trickle down with the dollar index down -0.74% at 79.123. Crude oil was higher today, with WTI crude settling up 0.4% at $106.58/barrel and Brent crude up 1.17% at $125.57/barrel. Gold settled higher by 0.9% at $1,698.70/ounce.

The unofficial closing bells put the DJIA up more than 70 points to 12,907.87 (0.55%), the NASDAQ rose more than 34 points (1.18%) to 2,970.42, and the S&P 500 rose 0.98% or more than 13 points to 1,365.91.

There were several analyst upgrades and downgrades today, including Apple Inc. (NASDAQ: AAPL) reiterated as ‘buy’ with target price raised from $600 to $660 at Goldman Sachs; ARM Holdings PLC (NASDAQ: ARMH) raised to ‘overweight’ at Morgan Stanley; Qualcomm Inc. (NASDAQ: QCOM) reiterated as ‘buy’ with a $72 target price at Argus; Zynga Inc. (NASDAQ: ZNGA) started as ‘hold’ at Canaccord Genuity; and Halozyme Therapeutics Inc. (NASDAQ: HALO) started as ‘overweight’ at Barclays.

Earnings reports since markets closed last night have led to some price changes as of the last half hour of trading today: Coldwater Creek Inc. (NASDAQ: CWTR) is up 0.9% at $1.02; Flotek Industries Inc. (NYSE: FTK) is up 9.7% at $12.11; Hot Topic Inc. (NASDAQ: HOTT) is up 13.4% at $9.97 after posting a new 52-week high of $10.11; Korn/Ferry International (NYSE: KFY) is up 0.3% at $15.33; A123 Systems Inc. (NASDAQ: AONE) is down -2.5% at $1.56; Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) is up 5.2% at $10.76; Fuel Systems Solutions Inc. (NASDAQ: FSYS) is down -2.2% at $25.74; JinkoSolar Holding Co. Ltd. (NYSE: JKS) is down -6.9% at $5.54 (more coverage here); Navistar International Corp. (NYSE: NAV) is down -2% at $39.25 (more coverage here); NeurogesX Inc. (NASDAQ: NGSX) is down -20% at $0.53 (more coverage here); Smithfield Foods Inc. (NYSE: SFD) is down -2.2% at $22.31 (more coverage here); Stein Mart Inc. (NASDAQ: SMRT) is down -8.6% at $6.38 (more coverage here); and Suntech Power Holdings Co. Ltd. (NYSE: STP) is down -1.4% at $2.89.

Other standouts from today include the following stocks:

Verso Paper Corp. (NYSE: VRS) is up 77% at $2.16. The paper maker will issue new debt of $345 in senior secured notes and has issued a tender offer for $315 million in 11.5% senior unsecured notes outstanding.

Stanley Furniture Co. Inc. (NASDAQ: STLY) is up about 20% at $4.29. The wood furniture maker has announced that it expects to receive a payment of about $40 million as a result of an anti-dumping ruling against Chinese furniture makers.

Mueller Water Products (NYSE: MWA) is up more than 21% at $3.46. The maker of water transmission, distribution, and measurement products is selling its pipe and foundry business for about $100 million in cash and other considerations. More coverage here.

Sunshine Heart Inc. (NASDAQ: SSH) is down more than -8% at $11.00. The medical device maker came public on February 16th, and is nearing the dreaded busted IPO line.

Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ) is down more than -13% at $5.65 after posting a new 52-week low of $5.60 earlier. The medical technology company posted a dismal fourth-quarter earnings report earlier this week and has just set its second record-low of the week as well.

Stay tuned for Friday. We have noted the following events on the schedule (all times Eastern):

8:30 a.m. – Non-farm employment report
8:30 a.m. – International trade report
10.00 a.m. – Wholesale trade report

Paul Ausick

Filed under: 24/7 Wall St. Wire Tagged: AAPL, ACHN, AONE, ARMH, CWTR, FSYS, FTK, HALO, HOTT, JKS, KFY, MWA, NAV, NGSX, QCOM, SFD, SMRT, SSH, STLY, STP, VRS, ZLTQ, ZNGA

Mid-day Movers (MNI, CSTR, CYBI, NGSX, SPF)

Paul Ausick — Tue, 07 Feb 2012 17:02:17 +0000

At about noon, the DJIA is still up about 35 points at about 12,880, the Nasdaq is up some about 8 points at around 2,910, and the S&P 500 is up about 2.5 points to 1,347. News that Greece has nearly closed a deal on its debt swap is boosting markets in Europe and the US, and pushing up Asian futures as well. Another good report on US unemployment is out, this one indicating that US job openings are at their highest level since August 2008.

Among the major movers at around noon today are The McClatchy Co. (NYSE: MNI), Coinstar Inc. (NASDAQ: CSTR), Cybex International Inc. (NASDAQ: CYBI), NeurogesX Inc. (NASDAQ: NGSX), and Standard Pacific Corp. (NYSE: SPF).

Shares of McClatchy are up about 25% at $2.79. About 2.4 million shares have been traded so far today, compared with a 3-month daily average of about 1.2 million shares traded. The newspaper company reported stronger-than-expected earnings today. More coverage here.

Coinstar is up nearly 19% at $59.95 after posting a new 52-week high of $60.81 earlier. More than 10 million shares have traded this morning, compared with a 3-month daily average of around 1.1 million. The video rental company will join with Verizon Communications Inc. (NYSE: VZ) to offer a streaming video service to compete with Netflix Inc. (NASDAQ: NFLX) and others. We have more coverage here and here.

Cybex is up nearly 22% at $1.45 after posting a new 52-week high of $1.55 earlier. About 242,000 shares have traded this morning, compared with a 3-month daily average of less than 40,000. The sporting goods firm has settled a product liability suit for $19.5 million.

NeurogesX is down nearly -23% at $0.89. About 1.8 million shares have traded by mid-day, compared with a daily average of about 220,000. The pharmaceuticals firm has received a query from the Food and Drug Administration regarding the efficacy of its pain-relief patch.

Standard Pacific shares are up more than 13% at $4.59 after posting a new 52-week high of $4.85 earlier today. More than 9 million shares have already traded this morning, compared with a 3-month daily average of about about 2 million shares. The homebuilder posted good earnings today and reported that orders are up 8% in January.

Paul Ausick

Filed under: 24/7 Wall St. Wire Tagged: CSTR, CYBI, MNI, NGSX, SPF

Top Day Trader Alerts (NLST, SPWRA, SPWRB, NGSX, PSUN, SMTL, AMAT)

Douglas A. McIntyre — Tue, 17 Nov 2009 13:58:57 +0000

These are this Tuesday’s top day trader and active trader alerts with more details and analysis linked through to each stock over at VSInvestor.com:

Netlist Inc. (NLST) is seeing small profit taking after a 500% run in the last week.

SunPower Corporation (NASDAQ: SPWRA) (NASDAQ: SPWRB) is down 13% on accounting irregularities and two downgrades.

NeurogesX, Inc. (NASDAQ: NGSX) is up 11% but off last night’s highs after an FDA pain patch approval.

Pacific Sunwear (NASDAQ: PSUN) is down 20% on wider losses and poor guidance.

Semitool, Inc. (NASDAQ: SMTL) is up 30% on what has to be record trading volume on the Applied Materials Inc. (NASDAQ: AMAT) acquisition.

You can join our open email distribution list to hear more news on top day trading alerts, key analyst upgrades and downgrades, Buffett and other investment gurus, IPOs, secondary offerings, private equity, mergers, and more.

JON C. OGG

Posted in Active Trader, Pre-Market Activity, Trading Alert Tagged: AMAT, NGSX, NLST, PSUN, SMTL, SPWRA, SPWRB

Top Pre-Market Analyst Downgrades (BRY, BBG, BG, CBST, GSX, KNL, WFR, SIRO, TXCO)

Douglas A. McIntyre — Fri, 05 Dec 2008 07:32:18 +0000

These are the top pre-market downgrades from Wall Street analysts this Friday morning:

Berry Petroleum (BRY) Cut to Market Perform at Morgan Keegan.
Bill Barrett (BBG) Cut to Market Perform at Morgan Keegan.
Bunge (BG) Cut to Underperform at Merrill Lynch.
Cubist Pharma (CBST) Cut to Perform at Oppenheimer.
Gasco Energy (GSX) Cut to Market Perform at Morgan Keegan.
Knoll (KNL) Cut to Sell at Goldman Sachs.
MEMC (WFR) Started as Underweight at Morgan Stanley.
Sirona Dental (SIRO) Cut to Neutral at Baird.
TXCO Resources (TXCO) Cut to Market Perform at Morgan Keegan.

Jon C. Ogg
December 5, 2008

Posted in Analyst Calls Tagged: BBG, BG, BRY, CBST, GSX, KNL, SIRO, TXCO, WFR

The 52-Week Low Club (S)(NT)(GCI)

Douglas A. McIntyre — Thu, 28 Feb 2008 16:17:03 +0000

Nortel (NT) Nine-to-one this dog never hits bottom. Down to $9.05 from 52-week high of $30.

Mylan (MYL) Market unhappy about quartery results. Sells off to $12 from 52-week high of $22.90.

Gannett (GCI) Newspaper companies in flat spin. Drops to $30.26 from 52-week high of $61.68.

Sprint (S) drops dividend and loses a ton of money. Dips to $7.75 from 52-week $23.42.

Journal Register (JRC) Another newspaper down for the count. Sell down to $1.07 from 52-week high of $7.23.

EpiCept (EPTC) Europe drug authority turns down product. Drops to $.87 from 52-week high of $4.89.

Neurogesx (NGSX) Bad trial data. Falls to $3.62 from 52-week high of $10.99.

Borland Software (BORL) Rough earnings. Down to $1.93 from 52-week high of $6.22.

Douglas A. McIntyre

Full Research Summary (APR 10, 2007)

Douglas A. McIntyre — Tue, 10 Apr 2007 07:21:04 +0000

ADLR cut to Mkt Perform at FBR; cut to Neutral at First Albany..
ADSK raised to Buy at Goldman Sachs.
AMD raised to Neutral at UBS.
AMAT raised to Buy at B of A.
AMTD started as Outperform at BMO Capital.
ASML cut to Mkt Weight at Thomas Weisel.

BHP raised to Neutral at Prudential.
CNXT cut to Sell at Roth Capital.
CSX cut to Neutral at JPMorgan.
CYCC started as Buy at Cantor Fitzgerald.
DA cut to Neutral at Prudential.
DSUP started as Hold at BB&T.
ESRX cut to Outperform at CIBC.
FITB started as MKt Perform at Morgan Keegan.
GSX cut to Mkt Perform at Wachovia.
LJPC started as Buy at AGEdwards.
MGI started as Neutral at Calyon.
MHS started as Sector Perform at CIBC.
MOS cut to Mkt Perform at BMO.
MSCC raised to Buy at Jefferies.
NYX started as Buy at Citigroup.
OPXT started as Buy at First Albany.
OXPS started as Outperform at BMO Capital.
ORCL raised to Buy at Goldman Sachs.
STX cut to Buy at Needham.
TIN cut to Neutral at Prudential.
VARI cut to Neutral at UBS.
VOD raised to Peer Perform at Bear Stearns.
VSEA cut to Mkt Weight at Thomas Weisel.
WU started as Buy at Calyon.

Jon C. Ogg
April 10 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Earlybird Analyst Calls (APR 10, 2007)

Douglas A. McIntyre — Tue, 10 Apr 2007 06:32:31 +0000

ADLR cut to Mkt Perform at FBR.
ADSK raised to Buy at Goldman Sachs.
AMD raised to Neutral at UBS.
AMAT raised to Buy at B of A.
ASML cut to Mkt Weight at Thomas Weisel.
BHP raised to Neutral at Prudential.

CSX cut to Neutral at JPMorgan.
CYCC started as Buy at Cantor Fitzgerald.
DA cut to Neutral at Prudential.
ESRX cut to Outperform at CIBC.
FITB started as MKt Perform at Morgan Keegan.
GSX cut to Mkt Perform at Wachovia.
MGI started as Neutral at Calyon.
MHS started as Sector Perform at CIBC.
MSCC raised to Buy at Jefferies.
OPXT started as Buy at First Albany.
ORCL raised to Buy at Goldman Sachs.
TIN cut to Neutral at Prudential.
VARI cut to Neutral at UBS.
VSEA cut to Mkt Weight at Thomas Weisel.
WU started as Buy at Calyon.

Jon C. Ogg
April 10, 2007

Best & Worst Healthcare and Biotech Mutual Funds

Douglas A. McIntyre — Fri, 02 Mar 2007 03:55:51 +0000

by H.S. Ayoub
BioHealth Investor.com

Since the market’s large drop on Tuesday investors have been a little wary of the near future outlook. This may be a good time to start looking at safer, more diversified biotech and healthcare investment vehicles.

Biotech ETFs are a good play, and mutual funds of good record will also prove beneficial. Investors could still trade the smaller biotechs, but a chunk of the capital should be placed in larger baskets such as ETFs and Funds to better withstand a larget market crash when, not if, it happens again.

In the Thursday issue of the Wall Street Journal, the regular feature Mutual Fund Scorecard showcased the very best and worst performing healthcare and biotechnology mutual funds.

The following is a summary. The 3 and 5 year returns are annualized.

LARGEST IN ASSETS

1. Vanguard Health Care (VGHCX)
Assets= $16,662.2 mill
YTD= +1.7%
1-Year= +10.4%
3-Year= +10.9%
5-Year= +10%
Top Holdings=
Eli Lilly (LLY)
SCHERING PLOUGH (SGP)
ROCHE HOLDING
FOREST LABS (FRX)
SANOFI-SYNTHELABO

2. Fidelity Select Health Care (FSPHX)
Assets= $2,123.1 mill
YTD= +1.4%
1-Year= +4.3%
3-Year= +9.0%
5-Year= +6.1%
Top Holdings=
PFIZER (PFE)
JOHNSON & JOHNSON (JNJ)
MERCK (MRK)
UNITEDHEALTH GROUP (UNH)
AMGEN (AMGN)

3. T Rowe Price Health Sciences (PRHSX)
Assets= $1,776.7 mill
YTD= +2.6%
1-Year= +4.8%
3-Year= 11.1%
5-Year= 10.3%
Top Holdings=
GILEAD SCIENCES (GILD)
CEPHALON INC (CEPH)
GENENTECH INC (DNA)
AMGEN (AMGN)
UNITEDHEALTH GROUP (UNH)

4. Putnam Health Sciences A (PHSTX)
Assets= $1764.4 mill
YTD= +1.9%
1-Year= +3.1%
3-Year= +7.4%
5-Year= +4.4%
Top Holdings=AMGEN (AMGN)
JOHNSON & JOHNSON (JNJ)
Roche Holding
GENENTECH INC (DNA)
MEDTRONIC INC (MDT)

5. Fidelity Select Biotechnology (FBIOX)
Assets= $1462 mill
YTD= -1.7%
1-Year= -6.1%
3-Year= +4.9%
5-Year= 3.6%
Top Holdings=BIOGEN IDEC (BIIB)
CELGENE (CELG)
GENENTECH INC (DNA)
GILEAD SCIENCES (GILD)
GENZYME CORPORATION (GENZ)

YEAR-TO-DATE TOP PERFORMERS

1. Jennison Health Sciences A (PHLAX)
+5.7%

2. Fidelity Select Medical Delivery (FSHCX)
+4.7%

3. Live Oak Health sciences (LOGSX)
+4.0%

4. Janus Global Life Sciences (JAGLX)
+3.9%

5. BlackRock Healthcare A (MDHCX)
+3.8%

YEAR-TO-DATE WORST PERFORMERS

1. Quaker Biotech Pharma-Healthcare A (QBPAX)
-4.3%

2. J Hancock Health Sciences A (JHGRX)
-2.7%

3. Allianz RCM Biotechnology D (DRBNX)
-2.0%

4. Fidelity Select Biotechnology (FBIOX)
-1.7%

5. Rydex Biotechnology Inv (RYOIX)
-1.5%

http://www.biohealthinvestor.com/